STAGE IIA OVARIAN CANCER AJCC V6 AND V7
Clinical trials for STAGE IIA OVARIAN CANCER AJCC V6 AND V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIA OVARIAN CANCER AJCC V6 AND V7 trials appear
Sign up with your email to follow new studies for STAGE IIA OVARIAN CANCER AJCC V6 AND V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New chemo schedule tested to improve ovarian cancer outcomes
Disease control OngoingThis study tested whether giving the chemotherapy drug paclitaxel weekly works better than the standard every-3-weeks schedule for people with advanced ovarian, peritoneal, or fallopian tube cancer. All participants also received carboplatin, and some received the targeted drug b…
Matched conditions: STAGE IIA OVARIAN CANCER AJCC V6 AND V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 03:29 UTC
-
Ovarian cancer showdown: which chemo combo works best?
Disease control OngoingThis study tests two different chemotherapy combinations (carboplatin+paclitaxel vs oxaliplatin+capecitabine), with or without the targeted drug bevacizumab, as first treatment for mucinous ovarian or fallopian tube cancer. About 50 patients with newly diagnosed or recurrent dise…
Matched conditions: STAGE IIA OVARIAN CANCER AJCC V6 AND V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:06 UTC